openPR Logo
Press release

Chronic Lower Back Pain Market Study Explores Industry Growth Toward $10.05 Billion

08-18-2026 07:13 AM CET | Health & Medicine

Press release from: The Business Research Company

Chronic Lower Back Pain Market

Chronic Lower Back Pain Market

Understanding the chronic lower back pain market reveals promising growth prospects driven by technological innovations and evolving treatment approaches. This sector is witnessing significant advancements aimed at addressing the complex needs of patients suffering from persistent back pain, with new therapies and personalized care strategies shaping its future landscape.

Projected Value and Expansion Rates in the Chronic Lower Back Pain Market
The chronic lower back pain market is set to experience steady expansion, reaching an estimated value of $10.06 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 4.6% during the forecast period. Key factors propelling this increase include heightened demand for non-invasive treatment options, broader adoption of digital therapeutic methods, growth in outpatient pain management services, a stronger emphasis on personalized medicine, and increased funding directed toward chronic pain research. Important trends influencing the market involve the growing use of multimodal pain management strategies, a rise in minimally invasive procedures, integration of digital pain monitoring technologies, expansion of personalized treatment plans, and a heightened focus on therapies that avoid opioid use.

The chronic lower back pain market size has grown steadily in recent years. It will grow from $8.04 billion in 2025 to $8.41 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing aging population, rising prevalence of musculoskeletal disorders, growing sedentary lifestyles, higher incidence of workplace-related back injuries, expanded access to diagnostic imaging.

Download a free sample of the chronic lower back pain market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Players Steering the Chronic Lower Back Pain Market
Several leading companies hold significant positions within the chronic lower back pain market, including Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy's Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., and Cara Therapeutics Inc.

Noteworthy Acquisition Enhancing Market Offerings
In a significant development in November 2023, Boston Scientific, a US-based biotechnology company, completed the acquisition of Relievant Medsystems, Inc. for $850 million. This strategic purchase strengthens Boston Scientific's chronic pain management portfolio by adding Relievant's intracept intraosseous nerve ablation system, designed specifically to treat vertebrogenic pain, a subtype of chronic lower back pain. Relievant Medsystems Inc. is recognized for its expertise in medical equipment manufacturing within the United States.

View the full chronic lower back pain market report:
https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovative Technologies Shaping the Chronic Lower Back Pain Market
Market leaders are advancing their portfolios by incorporating cutting-edge technologies such as BurstDR spinal cord stimulation (SCS). This proprietary therapy works by sending mild electrical pulses to modify pain signals traveling from the spinal cord to the brain, offering new hope for patients. For example, in May 2023, Abbott Laboratories received FDA approval for its Spinal Cord Stimulation devices, including the Proclaim SCS Family and Eterna SCS System, intended to treat chronic back pain. Abbott's devices feature the BurstDR stimulation waveform, which more closely mimics natural pain signaling and addresses the emotional aspects of pain, setting it apart from traditional tonic stimulation.

Breakdown of Key Segments Influencing Market Dynamics
This report segments the chronic lower back pain market according to various criteria:

1) By Type of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types of Pain
2) By Diagnosis Methods: Clinical History, Physical Examination, Imaging Guidelines, Pain Assessment
3) By End-User Categories: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Further detailed subcategories include:
- Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis
- Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis
- Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions
- Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis of the Facet Joints
- Radicular Pain: Sciatica, Nerve Root Compression
- Muscular Pain: Muscle Strain, Muscle Spasm
- Other Types of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

This segmentation reflects the comprehensive approach taken to understand and address the varied forms and causes of chronic lower back pain, facilitating targeted treatment and management strategies.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Lower Back Pain Market Study Explores Industry Growth Toward $10.05 Billion here

News-ID: 4606123 • Views:

More Releases from The Business Research Company

Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Industry
Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Indust …
The chronic pain market is on track for significant expansion in the coming years, driven by advances in treatment options and evolving healthcare delivery models. As demand grows for more personalized and effective pain management strategies, this sector is expected to witness considerable development through 2030. Let's explore the market's projected growth, key players, emerging trends, and important segments shaping its future. Chronic Pain Market Size and Forecast Through 2030
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Research Reveals Path To $3.31 Billion By 2030
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Research Reveals …
The chronic inflammatory demyelinating polyneuropathy (CIDP) market is poised for significant expansion in the coming years, driven by advancements in treatment and growing patient awareness. As the medical community continues to innovate, the market outlook suggests promising opportunities for enhanced therapies and improved patient care. Anticipated Market Growth and Size of the CIDP Market The CIDP market is projected to reach a value of $3.32 billion by 2030, growing at
Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR
Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR
The chronic cough market is positioned for significant expansion over the coming years, driven by advancements in treatment approaches and growing healthcare investments. Understanding the factors shaping this market, the key players involved, and emerging trends offers valuable insight into its future trajectory. Below is a detailed overview of the chronic cough market's size, leading companies, driving trends, and segmentation. Projected Growth Outlook for the Chronic Cough Market Through 2030
Choroidal Neovascularization Market Outlook Signals Expansion To $5.98 Billion Through 2030
Choroidal Neovascularization Market Outlook Signals Expansion To $5.98 Billion T …
The choroidal neovascularization market is on track for considerable expansion as we approach 2030. Advances in treatment options and rising awareness of eye health are setting the stage for strong growth in this specialized ophthalmic sector. Let us explore the projected market size, key players, emerging trends, and detailed segment insights shaping this industry. Forecasted Growth and Market Size of the Choroidal Neovascularization Market The global choroidal neovascularization market is

All 5 Releases


More Releases for Pain

Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain. Personalized Treatment for Every Pain Disorder Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe. By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods. So, have a pain-free life with easy-to-use pain relief
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction: The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes. In this article,
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical